Volume 4, Issue 1

 

ارسال های اخیر

  • Comparison of Tc-99m Ethylenedicysteine (Tc-99m EC) with Tc-99m DPTA in evaluation of renal disease [Persian] 

    Eftekhari, Mohammad؛ Vakili, Arsalan؛ Alavi, Mehrosadat؛ Sina, Alireza؛ Mirhosseini, Mazyar؛ Saghari, Mohsen (Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 1996-12-01)
    Tc-99m-EC is a new renal radiopharmaceutical introduced as an alternative for Tc-99m MAG3. Twenty-three normal volunteers and patients in different .stages of renal disease were evaluated with Te-99m EC and Tc-99m DTPA. ...

  • The labeling of platelet with Tc-99m and In-111 [Persian] 

    Najafi, Reza؛ Ghotbi, Zahra؛ Hadizad, Tayebeh (Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 1996-12-01)
    We separated platelets from whole blood and incorporated them into In-Ill and Te-99m agents. Sn-GHA, Tropolone, Oxine (sulphate) and HMPAO were used to diffuse radionuclides into the platelets. The effects of time, ...

  • The new direction of nuclear medicine 

    Greyson, David (Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 1996-12-01)
    The role of the nuclear medicine has changed, from the early days when it was the only alternative to x-rays, to the present, when nuclear images are interpreted in light of specific metabolic processes, not anatomy. The ...

  • "Recovery" of In-111 Chloride uptake in spleen and bone marrow, after chemotherapy for acute leukemia 

    Spencer, Richard؛ Karimeddini, Mozafareddin (Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 1996-12-01)
    A man with acute myelogenous leukemia, treated with chemotherapy, had a decrease in circulating formed blood elements. Bone marrow biopsy revealed necrosis. Imaging with In-Ill chloride demonstrated activity in the liver, ...

  • Clinical evaluation of liothyronine (Iran Hormone): Comparison with Cytomel [Persian] 

    Azizi, Fereidoun (Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 1996-12-01)
    In order to evaluate the effect of liothyronine formulated by Iran Hormone Co.(LT3,IH), 20 patients with primary hypothyroidism received 25mg LT3-IH daily. Another 40 hypothyroids were randomly divided into 4 groups and ...